Back to search results

Observational Study of Inflammatory Genes in Psoriasis

This observational study is looking at inflammatory genes in people with psoriasis. Researchers want to understand how these genes contribute to the inflammation seen in psoriasis. The study will measure inflammatory genes in participants. You may be able to join if you have a clinical diagnosis of psoriasis, are 19 years or older, and have any Fitzpatrick skin type (a way to classify skin based on how it reacts to sunlight). People with a history of keloids (raised scars) or those who do not have photosensitive disease and are not on photosensitizing medications cannot join. The study aims to understand these genes better, which could help in managing psoriasis in the future. The current status of the study is unclear.

Study design
This is an observational study planning to enroll 13 participants. It is not a treatment study, but rather aims to understand more about psoriasis.
What's involved
The study involves measuring inflammatory markers. The time commitment for participants is not specified beyond a measurement at 1 day.
Compensation
Not stated in the trial record.
Follow-up
Inflammatory genes will be measured at 1 day. Further follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03125655

Regulation of Inflammatory Genes in Psoriasis

Recruiting
Not specifiedAges 19–99Observational
University of Alabama at Birmingham
~13 participants
Updated 2026-04-06 on ClinicalTrials.gov
What's tested:Inflammatory markers

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Inflammatory genes
Measured over 1 day

Conditions

Psoriasis
Inflammation

Explore related trials

Psoriasis

Where it's being run

1 sites across 1 states
Alabama1

Who to contact

Wendy Cantrell
[email protected]
205 502 9960
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Clinical diagnosis of psoriasis
Must be age 19 or older.
Must be Fitzpatrick skin type I, II, III, IV, V, VI.

Exclusion

Subjects who do not have photosensitive disease and are not on photosensitizing medications.
Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy).
Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.
Subjects who are pregnant.

What this trial measures

  • Inflammatory genes1 day

    TNF-alpha , IFN-alpha , IL-6, IL-8, IL-12 , IL-23, IL-4, IL-5 and IL-10